פאגאינטרון מזרק מוכן לשימוש 120 מק"ג

Nazione: Israele

Lingua: ebraico

Fonte: Ministry of Health

Principio attivo:

PEGINTERFERON ALFA 2B 120 MCG / 0.5 ML

Commercializzato da:

MERCK SHARP & DOHME ISRAEL LTD

Codice ATC:

L03AB10

Forma farmaceutica:

POWDER FOR SOLUTION FOR INJECTION

Via di somministrazione:

S.C

Prodotto da:

SCHERING-PLOUGH (BRINNY) IRELAND

Gruppo terapeutico:

PEGINTERFERON ALFA-2B

Indicazioni terapeutiche:

Peg- Intron is indicated for the treatment of adult patients with histologically proven chronic hepatitis C who have elevated transaminases without liver decompensation and who are positive for serum HCV-RNA or anti-HCV including naive patients with clinically stable HIV coinfection. The best way to use Peg- Intron in this indication is in combination with ribavirin. This combination is indicated in naive patients including patients with clinically stable HIV co-infection and in patients who have failed previous treatment with interferon alpha (pegylated or nonpegylated ) and ribavirin combination therapy or interferon alpha monotherapy. Interferon monotherapy including Peg-Intron is indicated mainly in case of intolerance or contraindication to ribavirin. Please refer also to the ribavirin physician's insert when Pegintron is to be used in combination with ribavirin.

Data dell'autorizzazione:

2009-02-01